Maplelane Capital’s Teladoc Health TDOC Stock Holding History

Maplelane Capital’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-500,000	Closed	-$41.9M	–	155
2019 Q4	$41.9M	Sell	500,000 -50,000	-9%	-$3.81M	1.13%	20
2019 Q3	$37.2M	Buy	+550,000	New	+$36.2M	0.84%	33

Other funds holding TDOC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Maplelane Capital's TDOC Position: Q1 2020 in Review

Maplelane Capital sold out of Teladoc Health (TDOC) in Q1 2020, closing a stake of 1 share.

Maplelane Capital first reported a position in TDOC in Q3 2019 and held it in 2 quarters. The position peaked at $0 in Q4 2019. 577 funds tracked by Wall St. Rank hold TDOC as of Q1 2020.

Maplelane Capital reported no remaining Teladoc Health position as of Q1 2020 after selling out during the quarter.
Maplelane Capital sold 1 Teladoc Health share in Q1 2020.
Maplelane Capital first reported a position in Teladoc Health in Q3 2019 and held it in 2 quarters.
Maplelane Capital's Teladoc Health position peaked at $0 in Q4 2019.
577 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2020.

Based on Maplelane Capital's 13F filing for Q1 2020, filed 15 May 2020.